Last reviewed · How we verify
NPH insulin and regular insulin
NPH insulin and regular insulin is a Small molecule drug developed by Cook County Health. It is currently FDA-approved.
At a glance
| Generic name | NPH insulin and regular insulin |
|---|---|
| Sponsor | Cook County Health |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes (NA)
- Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes (PHASE2)
- DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes (PHASE4)
- Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings (PHASE4)
- Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER) (PHASE4)
- Comparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients. (PHASE4)
- Comparison of Thrice-Daily Premixed Human Insulin with Basal-Bolus Therapy Among Patients with Poorly Controlled Type 2 Diabetes Mellitus (PHASE4)
- Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NPH insulin and regular insulin CI brief — competitive landscape report
- NPH insulin and regular insulin updates RSS · CI watch RSS
- Cook County Health portfolio CI
Frequently asked questions about NPH insulin and regular insulin
What is NPH insulin and regular insulin?
NPH insulin and regular insulin is a Small molecule drug developed by Cook County Health.
Who makes NPH insulin and regular insulin?
NPH insulin and regular insulin is developed and marketed by Cook County Health (see full Cook County Health pipeline at /company/cook-county-health).
What development phase is NPH insulin and regular insulin in?
NPH insulin and regular insulin is FDA-approved (marketed).